Human Vaccines & Immunotherapeutics is a monthly peer-reviewed medical journal covering research into vaccines and immunotherapeutics in humans. It was established in 2005 as Human Vaccines, and obtained its current name in 2012.[1] It is published by Taylor & Francis and the editor-in-chief is Ronald Ellis (FutuRx). According to the Journal Citation Reports, the journal had a 2013 impact factor of 3.643.[2]
| Discipline | Vaccinology |
|---|---|
| Language | English |
| Edited by | Ronald Ellis |
| Publication details | |
Former name(s) | Human Vaccines |
| History | 2005-present |
| Publisher | |
| Frequency | Monthly |
| 4.526 (2021) | |
| Standard abbreviations | |
| ISO 4 | Hum. Vaccines Immunother. |
| NLM | Hum Vaccin Immunother |
| Indexing | |
| ISSN | 2164-5515 (print) 2164-554X (web) |
| LCCN | 2011202528 |
| Links | |
References
edit- ^ "Publication History". Taylor & Francis. Retrieved 11 February 2015.
- ^ "Human Vaccines & Immunotherapeutics". 2013 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2014.
External links
edit
  | This article about an immunology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |